Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10362/185549
Título: | Platelet transfusion practice in the intensive care unit |
Autor: | Russell, Lene Azoulay, Elie Anthon, Carl Thomas Pène, Frédéric Akella, Padmastuti Mabrouki, Asma Puxty, Kathryn Nielsen, Lene Bjerregaard Andreasen, Jo Bønding Kander, Thomas Sjövall, Fredrik Hästbacka, Johanna Hvas, Christine Lodberg Van De Louw, Andry Chawla, Sanjay Bauer, Philippe R. Castro, Pedro Povoa, Pedro Coelho, Luis Fernandez, Sara Topeli, Arzu Barratt-Due, Andreas Barbaglio, Caterina Kochanek, Matthias Martin-Loeches, Ignacio Kentish-Barnes, Nancy |
Palavras-chave: | Critically ill Intensive care Platelet transfusions Thrombocytopenia Critical Care and Intensive Care Medicine |
Data: | 2025 |
Resumo: | Background: Platelet transfusions are frequent in the Intensive Care Unit (ICU), either as prophylaxis against bleeding complications or as treatment for bleeding. The European Society of Intensive Care Medicine guidelines for ICU patients generally recommend not using prophylactic platelet transfusions unless the platelet count falls below 10 × 109 cells/L in non-bleeding patients and make no recommendation for platelet transfusion threshold in non-massively bleeding patients with thrombocytopenia. Therefore, the decision to transfuse platelets is often left to clinical assessment by the treating physician. This study aims to describe current platelet transfusion preferences among ICU physicians. Methods: An online, anonymous survey consisting of 43 items was produced in two languages (French and English) and distributed by investigators in the Nine-I research network to ICU physicians in Europe and the United States of America. The survey evaluated platelet transfusion practices in ICU patients with and without bleeding, the presence of local guidelines, and factors influencing the decisions to transfuse platelets. Only completed surveys were analysed. Results: We received 997 surveys completed by ICU physicians. Overall, there was large heterogeneity in platelet transfusion practices between and within countries. In non-bleeding, thrombocytopenic medical ICU patients, most would transfuse prophylactic platelets at a platelet count threshold of 10 × 109 cells/L. Thirty percent would change their strategy in patients with bone marrow failure and either be more liberal (60%; 95% Confidence Limits 0.54, 0.66), more restrictive (31%; 0.26,0.36) or seek assistance. Higher thresholds were preferred in surgical patients, prior to procedures and in patients with bleeding. Only 173 (17%; 0.15,0.19) responded that they were confident about the clinical indications every time they prescribed a platelet transfusion. As for existing guidelines, only 123 (12%; 0.10,0.15) responded that they always read them. Colleagues' attitudes and departmental culture were important influencers on transfusion practice. Conclusion: Platelet transfusion practice in the ICU is heterogeneous, both between and within countries; guidelines are often not used, and there is often uncertainty about the clinical indication. |
Descrição: | Funding Information: Dr. Kentish-Barnes\u2019 institution received funding from the French Ministry of Health. Professor Azoulay\u2019s institution received funding from Fisher & Paykel, MSD, Pfizer, Baxter, and Gilead, and he received funding from Gilead, Baxter, Alexion, Ablynx, and Pfizer. Professor P\u00E9ne has received lecture and consulting fees from GILEAD outside of this work. Dr. Castro has received honoraria for scientific collaboration (Pfizer, MSD, Gilead, AbbVie) and advisory board (Alexion, Janssen, Sanofi, Gilead). Professor Povoa has received honoraria for lectures (Gilead, Pfizer, Mundipharma, MSD) and participation in advisory boards (Biocodex, Gilead). The rest of the authors have no competing interests. Funding Information: Open access funding provided by Copenhagen University. Dr Russell received funding for this study from the Dagmar Marshalls Foundation. The Memorial Sloan Kettering Cancer Center part of the study was supported by the Core Grant, Grant/Award Number: P30CA008748; Department of Anaesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. None of the funders had any influence on the design, conduct, or reporting of the study. Publisher Copyright: © The Author(s) 2025. |
Peer review: | yes |
URI: | http://hdl.handle.net/10362/185549 |
DOI: | https://doi.org/10.1186/s13613-025-01494-4 |
ISSN: | 2110-5820 |
Aparece nas colecções: | Home collection (NMS) |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
s13613-025-01494-4.pdf | 1,25 MB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.